Outset Medical, Inc. (OM)

Outset Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.94	35.01	124.01	68.51	73.22	182.35
Short-Term Investments	102.69	133.94	34.67	134.82	214.28	157.14
Cash & Short-Term Investments	136.63	168.95	158.69	203.32	287.5	339.49
Cash Growth	-23.52%	6.47%	-21.95%	-29.28%	-15.31%	7.82%
Receivables	30.41	28.33	35.62	32.98	28.07	25.6
Inventory	44.99	47.61	59.39	49.22	51.48	39.19
Prepaid Expenses	4.2	6	4.53	5.7	6.6	5.53
Total Current Assets	216.22	250.88	258.22	291.22	373.65	409.8
Property, Plant & Equipment	9.62	9.47	12.07	18.65	21.99	20.2
Other Long-Term Assets	4.57	4.15	5.5	3.93	4.48	33.47
Total Assets	230.41	264.5	275.8	313.8	400.12	463.46

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.29	0.55	3.86	5.83	0.6	1.76
Accrued Expenses	23.31	16.1	21.94	26.7	30.64	34.72
Current Portion of Leases	2.36	1.74	1.8	1.59	1.32	1.15
Current Unearned Revenue	13.47	13.8	12.75	11.73	8.66	6.34
Other Current Liabilities	1.02	5.44	5.03	9.47	10.73	7.72
Total Current Liabilities	44.45	37.63	45.38	55.32	51.95	51.7
Long-Term Debt	98.37	96.24	197.38	130.11	96.34	29.76
Long-Term Leases	4.05	3.27	2.68	4.48	5.58	6.89
Long-Term Unearned Revenue	0.22	0.41	0.84	0.1	0.15	0.31
Other Long-Term Liabilities	-	-	2.7	0.9	0.11	0.72
Total Liabilities	147.1	137.54	248.98	190.92	154.13	89.38

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.02	0.02	0	0.05	0.05	0.05
Additional Paid-In Capital	1,307	1,298	1,116	1,085	1,035	1,000
Retained Earnings	-1,223	-1,171	-1,090	-961.75	-788.95	-625.99
Comprehensive Income & Other	-0.24	0.17	0.04	0.07	-0.56	-0.18
Total Common Equity	83.31	126.95	26.82	122.89	245.99	374.08
Shareholders' Equity	83.31	126.95	26.82	122.89	245.99	374.08
Total Liabilities & Equity	230.41	264.5	275.8	313.8	400.12	463.46

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	104.78	101.25	201.86	136.19	103.23	37.81
Net Cash (Debt)	31.85	67.7	-43.17	67.14	184.27	301.68
Net Cash Growth	-60.17%	-	-	-63.57%	-38.92%	9.20%
Net Cash Per Share	1.72	4.45	-12.47	20.31	57.39	99.26
Filing Date Shares Outstanding	18.87	18.31	3.59	3.37	3.24	3.16
Total Common Shares Outstanding	18.87	18.17	3.53	3.35	3.23	3.15
Working Capital	171.77	213.25	212.84	235.9	321.7	358.11
Book Value Per Share	4.41	6.99	7.60	36.63	76.13	118.78
Tangible Book Value	83.31	126.95	26.82	122.89	245.99	374.08
Tangible Book Value Per Share	4.41	6.99	7.60	36.63	76.13	118.78
Machinery	-	19.47	18.6	18.73	16.16	12.47
Construction In Progress	-	0.52	0.64	0.77	4.77	0.87
Leasehold Improvements	-	9.58	9.69	9.62	5.04	4.86

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error